Strategic targets for primary prevention of allergic disease in childhood

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 53, Issue SUPPL. 45, 1998, Pages 72-76

  Holt, P G ^a   Macaubas, C ^a   Sly, P D ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; EPITOPE; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 9;

ALLERGENICITY; ALLERGIC DISEASE; CONFERENCE PAPER; COST EFFECTIVENESS ANALYSIS; CROSS REACTION; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE CONTROL; GENE EXPRESSION; GENOTYPE; HUMAN; IMMUNOPROPHYLAXIS; IMMUNOSTIMULATION; INFLAMMATION; POLYMERASE CHAIN REACTION; PRIMARY PREVENTION; PRIORITY JOURNAL; SENSITIZATION;

ALLERGENS; ANTI-INFLAMMATORY AGENTS; CHILD; ENVIRONMENTAL EXPOSURE; HUMANS; HYPERSENSITIVITY; IMMUNITY, MATERNALLY-ACQUIRED; T-LYMPHOCYTES; TH1 CELLS; VACCINES;

EID: 0031696831     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/j.1398-9995.1998.tb04944.x     Document Type: Conference Paper

References (47)

1. Kondo N, Kobayashi Y, Shinoda S, et al. Cord blood lymphocyte responses to food antigens for the prediction of allergic disorders. Arch Dis Child 1992;67:1003-7.
2. Piccinni M-P, Mecacci F, Sampognaro S, et al. Aeroallergen sensitization can occur during fetal life. Tnt Arch Allergy Immunol 1993:102:301-3.
3. Piastra M, Stabile A, Fioravanti G, Castagnola M, Pani G, Ria F Cord blood mononuclear cell responsiveness to betalactoglobulin: T-cell activity in "atopy-prone" and "nonatopy-prone" newborns. Tnt Arch Allergy Immunol 1994:104:358-65.
4. Holt PG, O'Keeffe P0, Holt BJ, et al. T-cell "priming" against environmental allergens in human neonates: sequential deletion of food antigen specificities during infancy with concomitant expansion of responses to ubiquitous inhalant allergens. Pediatr Allergy Immunol 1995;6: 85-90.
5. Jones AC, Miles EA, Warner JO, Colwell BM, Bryant TN, Warner JA. Fetal peripheral blood mononuclear cell proliferative responses to mitogenic and allergenic stimuli during gestation. Pediatr Allergy Immunol 1996:7:109-16.
6. Prescott SL, Macaubas C, Holt BJ, et al. Transpiacental priming of the human immune system to environmental allergens: universal skewing of initial T-cell responses towards the Th-2 cytokine profile. J Immunol 1998 (in press).
7. Prescott SL, Macaubas C, Yabuhara A, et al. Developing patterns of T cell memory to environmental allergens in the first two years of life. mt Arch Allergy Immunol 1997;113:75-9.
8. Yabuhara A, Macaubas C, Prescott SL, et al. Th-2-polar- ised immunological memory to inhalant allergens in atopics is established during infancy and early childhood. Clin Exp Allergy 1997;27:1261-9.
9. Macaubas C, Sly PD, Burton P, et al. Differential regulation of T-cell responses to inhalant versus dietary allergens during early childhood. Am J Respir Cell Mol Biol (submitted).
10. Holt PG, Macaubas C. Development of long term tolerance versus sensitisation to environmental allergens during the perinatal period. Curr Opin Iminunol 1997;9:782-7.
11. Wegmann TG, Lin H, Guilbert L, Mosmann TR. Bidirectional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a Th2 phenomenon? Immunol Today 1993;14:353-6.
12. Holt PG, Sly PD, Bjorkstén B. Atopic versus infectious diseases in childhood: a question of balance? Pediatr Allergy Immunol 1997;8:53-8.
13. Holt PG. Environmental factors and primary T-cell sensitisation to inhalant allergens in infancy: reappraisal of the role of infections and air pollution. Pediatr Allergy Immunol 1995;6:1-10.
14. Inagaki H, Suzuki T, Nomoto K, Yoskikai Y. Increased susceptibility to primary infection with Listeria monocyto genes in germfree mice may be due to lack of accumulation of L-selectin CD44 T cells in sites of inflammation. Infect Immun 1996;64:3280-7.
15. Sudo N, Sawamura S-A, Tanaka K, Aiba Y, Kubo C, Koga Y. The requirement of intestinal bacterial flora for the development of an IgE production system fully susceptible to oral tolerance induction. J Immunol 1997;159:1739-45.
16. Ridge JP, Fuchs EJ, Matzinger P. Neonatal tolerance revisited: turning on newborn T cells with dendritic cells. Science 1996;271:1723-6.
17. Singh RR, Hahn BH, Sercarz EE. Neonatal peptide exposure can prime T cells, and upon subsequent immunization induce their immune deviation: implications for antibody vs. T cell-mediated autoimmunity. J Exp Med 1996;183:1613-22.
18. Chen N, Gao Q, Field EH. Expansion of memory Th2 cells over Th1 cells in neonatal primed mice. Transplantation 1995 ;60:1187-93.
19. Holt PG. Primary allergic sensitisation to environmental antigens: perinatal T-cell prhning as a determinant of responder phenotype in adulthood. J Exp Med 1996; 183:1297-1301.
20. Holt PG, McMenamin C, Nelson D. Primary sensitisation to inhalant allergens during infancy. Pediatr Allergy Immunol 1990;1:3-13.
21. Holt PG, Clough JB, Holt BJ, et al. Genetic "risk" for atopy is associated with delayed postnatal maturation of T-cell competence. Clin Exp Allergy 1992;22:1093-9.
22. Rinas U, Horneff G, Wahn V. Interferon-y production by cord-blood mononuclear cells is reduced in newborns with a family history of atopic disease and is independent from cord blood IgE-levels. Pediatr Allergy Immunol 1993;4: 60-4.
23. Tang MLK, Kemp AS, Thorburn J, Hill DJ. Reduced interferon-'y secretion in neonates and subsequent atopy. Lancet 1994;344:983-6.
24. Martinez FD, Stern DA, Wright AL, Holberg Ci, Taussig LM, Halonen M. Association of interleukin-2 and interferon- y production by blood mononuclear cells in infancy with parental allergy skin tests and with subsequent development of atopy. J Allergy Cliii Immunol 1995;96:652-60.
25. Liao SY, Liao TN, Chiang BL, et al. Decreased production of IFN-y and increased production of IL-6 by cord blood mononuclear cells of newborns with a high risk of allergy. Clin Exp Allergy 1996;26:397-405.
26. Shirakawa T, Enomoto T, Shimazu 5, Hopkin JM. Inverse association between tuberculin responses and atopic disorder. Science 1997;275:77-9.
27. Prescott SL, Sly PD, Holt PG. Reduced responsiveness to DPT vaccination during infancy is associated with elevated serum IgE. Lancet 1998 (in press).
28. Burrows B, Martinez F, Halonen M, Barbee R, Cline M. Association of asthma with serum IgE levels and skin-test reactivity to allergens. N Engl J Med 1989;320:271-7.
29. Woolcock AJ, Peat 1K, Trevillion LM. Is the increase in asthma prevalence linked to increase in allergen load? Allergy 1995;50:935-40.
30. Holt PG, Sly PD. Allergic respiratory disease: strategic targets for primary prevention during childhood. Thorax 1997;52:1-4.
31. Johnston SL, Pattemore PK, Sanderson G, et al. The relationship between upper respiratory infections and hospital admissions for asthma: a time-trend analysis. Am J Respir Crit Care Med 1996;154:654-60.
32. Weiss ST. Diet as a risk factor for asthma. Ciba Found Symp 1997;206:244-57.
33. Bjbrkstén B. Risk factors in early childhood for the development of atopic diseases. Allergy 1994;49:400-7.
34. Nelson DJ, McWilliam AS, Haining 5, Holt PG. Modulation of airway intraepithelial dendritic cells following exposure to steroids. Am J Respir Crit Care Med 1995;151:475-81.
35. Holt PG, Thomas JA. Steroids inhibit uptake and/or processing but not presentation of antigen by airway dendritic cells. Immunology 1997;91:145-50.
36. Moller GM, Overbeek SE, van Helden-Meeuwsen CG, et al. Increased numbers of dendritic cells in the bronchial mucosa of atopic asthmatic patients: downregulation by inhaled corticosteroids. Clin Exp Allergy 1996;26:517-24.
37. Tunon-de-Lara JM, Redington AE, Bradding P, et al. Dendritic cells in normal and asthmatic airways: expression of the a subunit of the high affinity immunoglobulin E receptor (FcERI-A). Clin Exp Allergy 1996;26:648-55.
38. Panina-Bordignon F, Mazzeo D, Lucia PD, et al. Beta2- antagonists prevent Thi development by selective inhibition of interleukin-12. I Clin Invest 1997;15:1513-19.
39. Peat 1K, Gray EJ, Mellis CM, Leeder SR, Woolcock AJ. Differences in airway responsiveness between children and adults living in the same environment: an epidemiological study in two regions of New South Wales. Eur Respir J 1994;7:1805-13.
40. Holt PG. A potential vaccine strategy for asthma and allied atopic diseases in early childhood. Lancet 1994;344:456-8.
41. Holt PG. Immunoprophylaxis of atopy: light at the end of the tunnel? Immunol Today 1994;15:484-9.
42. Tomasi M, Dertzbaugh MT, Hearn T, Hunter RL. Strong mucosal adjuvanticity of cholera toxin within lipid particles of a new multiple emulsion delivery system for oral immunization. Eur J Immunol 1997;27:2720-5.
43. Collett JP, Shapiro S, Ernst P, et al. Effects of an immunostimulating agent on acute exacerbations and hospitalizations in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1997;156:1719-24.
44. Lehmann D, Coakley KJ, Coakley CA, et al. Reduction in the incidence of acute bronchitis by an oral Haemophilus influenzae vaccine in patients with chronic bronchitis in the highlands of Papua New Guinea. Am Rev Respir Dis 1991 ;144:324-30.
45. Alm iS, Lilja G, Pershagen G, Scheynius A. Early BCG vaccination and development of atopy. Lancet 1997; 350:400-3.
46. Strannegârd I-L, Larsson L-O, Wennergren G, Strannegârd O. Prevalence of allergy in children in relation to prior BCG vaccination and infection with atypical mycobacteria. Allergy 1998;53:249-54.
47. Rhodes J. Covalent chemical events in immune induction: fundamental and therapeutic aspects. Immunol Today 1996;17:436-41.